Engineering temperature sensitive live attenuated influenza vaccines from emerging viruses

Vaccine

Volumn 30, Issue 24, 2012, Pages 3691-3702

  Zhou, Bin ^a,b,c   Li, Yan ^a   Speer, Scott D ^a   Subba, Anju ^a,c   Lin, Xudong ^a,c   Wentworth, David E ^a,b,c  

^a WADSWORTH CENTER   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

^c J CRAIG VENTER INSTITUTE   (United States)

Author keywords

Heterologous protection; Influenza A virus; Live attenuated vaccine; RNA polymerase; Temperature sensitive

Indexed keywords

GLYCOPROTEIN; INFLUENZA VACCINE; VIRUS RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENOME; HUMAN; HUMAN CELL; INFLUENZA A (H1N1); INFLUENZA VIRUS A; INFLUENZA VIRUS A H1N1; LUNG; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; UNITED STATES; VIRUS GENE; VIRUS RECOMBINANT; VIRUS REPLICATION; VIRUS STRAIN;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; LUNG; MICE; MICE, INBRED BALB C; MUTATION; ORTHOMYXOVIRIDAE INFECTIONS; TEMPERATURE; VACCINES, ATTENUATED; VIRUS REPLICATION;

EID: 84860993740     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.03.025     Document Type: Article

References (59)

1. World Health Organization. Influenza (Seasonal) Fact sheet 211. Apr 1;(211). http://www.who.int/mediacentre/factsheets/fs211/en/2009.
2. Taubenberger J.K., Morens D.M. 1918 influenza: the mother of all pandemics. Emerg Infect Dis 2006, 12(January (1)):15-22.
3. Cox R.J., Brokstad K.A., Ogra P. Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines. Scand J Immunol 2004, 59(January (1)):1-15.
4. Wareing M.D., Tannock G.A. Live attenuated vaccines against influenza; an historical review. Vaccine 2001, 19(May (25-26)):3320-3330.
5. Zhu W., Higgs B.W., Morehouse C., Streicher K., Ambrose C.S., Woo J., et al. A whole genome transcriptional analysis of the early immune response induced by live attenuated and inactivated influenza vaccines in young children. Vaccine 2010, 28(April (16)):2865-2876.
6. Johnson P.R., Feldman S., Thompson J.M., Mahoney J.D., Wright P.F. Comparison of long-term systemic and secretory antibody responses in children given live, attenuated, or inactivated influenza A vaccine. J Med Virol 1985, 17(December (4)):325-335.
7. Sasaki S., He X.S., Holmes T.H., Dekker C.L., Kemble G.W., Arvin A.M., et al. Influence of prior influenza vaccination on antibody and B-cell responses. PLoS One 2008, 3(August (8)):e2975.
8. Gorse G.J., Belshe R.B. Enhancement of anti-influenza A virus cytotoxicity following influenza A virus vaccination in older, chronically ill adults. J Clin Microbiol 1990, 28(November (11)):2539-2550.
9. Clements M.L., Betts R.F., Murphy B.R. Advantage of live attenuated cold-adapted influenza A virus over inactivated vaccine for A/Washington/80 (H3N2) wild-type virus infection. Lancet 1984, 1(March (8379)):705-708.
10. Rhorer J., Ambrose C.S., Dickinson S., Hamilton H., Oleka N.A., Malinoski F.J., et al. Efficacy of live attenuated influenza vaccine in children: a meta-analysis of nine randomized clinical trials. Vaccine 2009, 27(February (7)):1101-1110.
11. Ashkenazi S., Vertruyen A., Arístegui J., Esposito S., McKeith D.D., Klemola T., et al. Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections. Pediatr Infect Dis J 2006, 25(October (10)):870-879.
12. Belshe R.B., Edwards K.M., Vesikari T., Black S.V., Walker R.E., Hultquist M., et al. Live attenuated versus inactivated influenza vaccine in infants and young children. N Engl J Med 2007, 356(February (7)):685-696.
13. Luce B.R., Nichol K.L., Belshe R.B., Frick K.D., Li S.X., Boscoe A., et al. Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24-59 months in the United States. Vaccine 2008, 26(June (23)):2841-2848.
14. Hoft D.F., Babusis E., Worku S., Spencer C.T., Lottenbach K., Truscott S.M., et al. Live and inactivated influenza vaccines induce similar humoral responses, but only live vaccines induce diverse T-cell responses in young children. J Infect Dis 2011, 204(September (6)):845-853.
15. Ambrose C.S., Levin M.J., Belshe R.B. The relative efficacy of trivalent live attenuated and inactivated influenza vaccines in children and adults. Influenza Other Respir Viruses 2011, 5(March (2)):67-75.
16. Maassab H.F. Adaptation and growth characteristics of influenza virus at 25 degrees C. Nature 1967, 213(February (5076)):612-614.
17. Maassab H.F., Bryant M.L. The development of live attenuated cold-adapted influenza virus vaccine for humans. Rev Med Virol 1999, 9(October (4)):237-244.
18. Murphy B.R., Coelingh K. Principles underlying the development and use of live attenuated cold-adapted influenza A and B virus vaccines. Viral Immunol 2002, 15(2):295-323.
19. Subbarao E.K., Park E.J., Lawson C.M., Chen A.Y., Murphy B.R. Sequential addition of temperature-sensitive missense mutations into the PB2 gene of influenza A transfectant viruses can effect an increase in temperature sensitivity and attenuation and permits the rational design of a genetically engineered live influenza A virus vaccine. J Virol 1995, 69(October (10)):5969-5977.
20. Subbarao E.K., Kawaoka Y., Murphy B.R. Rescue of an influenza A virus wild-type PB2 gene and a mutant derivative bearing a site-specific temperature-sensitive and attenuating mutation. J Virol 1993, 67(December (12)):7223-7228.
21. Parkin N.T., Chiu P., Coelingh K. Genetically engineered live attenuated influenza A virus vaccine candidates. J Virol 1997, 71(April (4)):2772-2778.
22. Jin H., Zhou H., Lu B., Kemble G. Imparting temperature sensitivity and attenuation in ferrets to A/Puerto Rico/8/34 influenza virus by transferring the genetic signature for temperature sensitivity from cold-adapted A/Ann Arbor/6/60. J Virol 2004, 78(January (2)):995-998.
23. Hickman D., Hossain M.J., Song H., Araya Y., Solorzano A., Perez D.R. An avian live attenuated master backbone for potential use in epidemic and pandemic influenza vaccines. J Gen Virol 2008, 89(November (Pt 11)):2682-2690.
24. Pena L., Vincent A.L., Ye J., Ciacci-Zanella J.R., Angel M., Lorusso A., et al. Modifications in the polymerase genes of a swine-like triple-reassortant influenza virus to generate live attenuated vaccines against 2009 pandemic H1N1 viruses. J Virol 2011, 85(January (1)):456-469.
25. Solorzano A., Ye J., Perez D.R. Alternative live-attenuated influenza vaccines based on modifications in the polymerase genes protect against epidemic and pandemic flu. J Virol 2010, 84(May (9)):4587-4596.
26. Song H., Nieto G.R., Perez D.R. A new generation of modified live-attenuated avian influenza viruses using a two-strategy combination as potential vaccine candidates. J Virol 2007, 81(September (17)):9238-9248.
27. Voeten J.T.M., Bestebroer T.M., Nieuwkoop N.J., Fouchier R.A.M., Osterhaus A.D.M.E., Rimmelzwaan G.F. Antigenic drift in the influenza a virus (H3N2) nucleoprotein and escape from recognition by cytotoxic T lymphocytes. J Virol 2000, 74(August (15)):6800-6807.
28. Gras S., Kedzierski L., Valkenburg S.A., Laurie K., Liu Y.C., Denholm J.T., et al. Cross-reactive CD8+ T-cell immunity between the pandemic H1N1-2009 and H1N1-1918 influenza A viruses. Proc Natl Acad Sci USA 2010, 107(July (28)):12599-12604.
29. Zhong W., Liu F., Dong L., Lu X., Hancock K., Reinherz E.L., et al. Significant impact of sequence variations in the nucleoprotein on CD8T cell-mediated cross-protection against influenza A virus infections. PLoS ONE 2010, 5(May (5)):e10583.
30. Kreijtz J.H.C.M., de Mutsert G., van Baalen C.A., Fouchier R.A.M., Osterhaus A.D.M.E., Rimmelzwaan G.F. Cross-recognition of avian H5N1 influenza virus by human cytotoxic T-lymphocyte populations directed to human influenza A virus. J Virol 2008, 82(June (11)):5161-5166.
31. Greenbaum J.A., Kotturi M.F., Kim Y., Oseroff C., Vaughan K., Salimi N., et al. Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population. Proc Natl Acad Sci USA 2009, 106(December (48)):20365-20370.
32. Rimmelzwaan G.F., Kreijtz J.H., Bodewes R., Fouchier R.A., Osterhaus A.D. Influenza virus CTL epitopes, remarkably conserved and remarkably variable. Vaccine 2009, 27(October (45)):6363-6365.
33. Wahl A., McCoy W., Schafer F., Bardet W., Buchli R., Fremont D.H., et al. T-cell tolerance for variability in an HLA class I-presented influenza A virus epitope. J Virol 2009, 83(September (18)):9206-9214.
34. Rimmelzwaan G.F., Boon A.C., Voeten J.T., Berkhoff E.G., Fouchier R.A., Osterhaus A.D. Sequence variation in the influenza A virus nucleoprotein associated with escape from cytotoxic T lymphocytes. Virus Res 2004, 103(July (1-2)):97-100.
35. Boon A.C., de Mutsert G., Graus Y.M., Fouchier R.A., Sintnicolaas K., Osterhaus A.D., et al. Sequence variation in a newly identified HLA-B35-restricted epitope in the influenza A virus nucleoprotein associated with escape from cytotoxic T lymphocytes. J Virol 2002, 76(March (5)):2567-2572.
36. Zhou B., Donnelly M.E., Scholes D.T., St George K., Hatta M., Kawaoka Y., et al. Single-reaction genomic amplification accelerates sequencing and vaccine production for classical and swine origin human influenza A viruses. J Virol 2009, 83(October (19)):10309-10313.
37. Jin H., Lu B., Zhou H., Ma C., Zhao J., Yang C.F., et al. Multiple amino acid residues confer temperature sensitivity to human influenza virus vaccine strains (FluMist) derived from cold-adapted A/Ann Arbor/6/60. Virology 2003, 306(February (1)):18-24.
38. Lawson C.M., Subbarao E.K., Murphy B.R. Nucleotide sequence changes in the polymerase basic protein 2 gene of temperature-sensitive mutants of influenza A virus. Virology 1992, 191(November (1)):506-510.
39. Zhou B., Li Y., Belser J.A., Pearce M.B., Schmolke M., Subba A.X., et al. NS-based live attenuated H1N1 pandemic vaccines protect mice and ferrets. Vaccine 2010, 28(November (50)):8015-8025.
40. Zhou B., Jerzak G., Scholes D.T., Donnelly M.E., Li Y., Wentworth D.E. Reverse genetics plasmid for cloning unstable influenza A virus gene segments. J Virol Methods 2011, 173(May (2)):378-383.
41. Neumann G., Watanabe T., Ito H., Watanabe S., Goto H., Gao P., et al. Generation of influenza A viruses entirely from cloned cDNAs. Proc Natl Acad Sci USA 1999, 96(August (16)):9345-9350.
42. Zhou B., Li Y., Halpin R., Hine E., Spiro D.J., Wentworth D.E. PB2 residue 158 is a pathogenic determinant of pandemic H1N1 and H5 influenza A viruses in mice. J Virol 2011, 85(January (1)):357-365.
43. Cox N.J., Kitame F., Kendal A.P., Maassab H.F., Naeve C. Identification of sequence changes in the cold-adapted, live attenuated influenza vaccine strain, A/Ann Arbor/6/60 (H2N2). Virology 1988, 167(December (2)):554-567.
44. Itoh Y., Shinya K., Kiso M., Watanabe T., Sakoda Y., Hatta M., et al. In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 2009, 460(August (7258)):1021-1025.
45. World Health Organization. Characteristics of the emergent influenza A (H1N1) viruses and recommendations for vaccine development. http://www.who.int/csr/resources/publications/swineflu/vaccine_recommendations/en/.
46. Wang W., Castelán-Vega J.A., Jiménez-Alberto Alicia Vassell R., Ye Z., Weiss C.D. A mutation in the receptor binding site enhances infectivity of 2009 H1N1 influenza hemagglutinin pseudotypes without changing antigenicity. Virology 2010, 407(November (2)):374-380.
47. Chen Z., Wang W., Zhou H., Suguitan A.L., Shambaugh C., Kim L., et al. Generation of live attenuated novel influenza virus A/California/7/09 (H1N1) vaccines with high yield in embryonated chicken eggs. J Virol 2010, 84(January (1)):44-51.
48. Treanor J., Perkins M., Battaglia R., Murphy B.R. Evaluation of the genetic stability of the temperature-sensitive PB2 gene mutation of the influenza A/Ann Arbor/6/60 cold-adapted vaccine virus. J Virol 1994, 68(December (12)):7684-7688.
49. Murphy B.R., Park E.J., Gottlieb P., Subbarao K. An influenza A live attenuated reassortant virus possessing three temperature-sensitive mutations in the PB2 polymerase gene rapidly loses temperature sensitivity following replication in hamsters. Vaccine 1997, 15(August (12-13)):1372-1378.
50. Tolpin M.D., Massicot J.G., Mullinix M.G., Kim H.W., Parrott R.H., Chanock R.M., et al. Genetic factors associated with loss of the temperature-sensitive phenotype of the influenza A/Alaska/77-ts-1A2 recombinant during growth in vivo. Virology 1981, 112(July (2)):505-517.
51. Murphy B.R., Markoff L.J., Hosier N.T., Massicot J.G., Chanock R.M. Production and level of genetic stability of an influenza A virus temperature-sensitive mutant containing two genes with ts mutations. Infect Immun 1982, 37(July (1)):235-242.
52. Snyder M.H., Betts R.F., DeBorde D., Tierney E.L., Clements M.L., Herrington D., et al. Four viral genes independently contribute to attenuation of live influenza A/Ann Arbor/6/60 (H2N2) cold-adapted reassortant virus vaccines. J Virol 1988, 62(February (2)):488-495.
53. Herlocher M.L., Clavo A.C., Maassab H.F. Sequence comparisons of A/AA/6/60 influenza viruses: mutations which may contribute to attenuation. Virus Res 1996, 42(June (1-2)):11-25.
54. Rey O., Nayak D.P. Nuclear retention of M1 protein in a temperature-sensitive mutant of influenza (A/WSN/33) virus does not affect nuclear export of viral ribonucleoproteins. J Virol 1992, 66(October (10)):5815-5824.
55. Liu T., Ye Z. Introduction of a temperature-sensitive phenotype into influenza A/WSN/33 virus by altering the basic amino acid domain of influenza virus matrix protein. J Virol 2004, 78(September (18)):9585-9591.
56. Garaigorta U., Falcon A.M., Ortin J. Genetic analysis of influenza virus NS1 gene: a temperature-sensitive mutant shows defective formation of virus particles. J Virol 2005, 79(December (24)):15246-15257.
57. Herlocher M.L., Maassab H.F., Webster R.G. Molecular and biological changes in the cold-adapted master strain A/AA/6/60 (H2N2) influenza virus. Proc Natl Acad Sci USA 1993, 90(July (13)):6032-6036.
58. Murakami S., Horimoto T., Mai L.Q., Nidom C.A., Chen H., Muramoto Y., et al. Growth determinants for H5N1 influenza vaccine seed viruses in MDCK cells. J Virol 2008, 82(November (21)):10502-10509.
59. Adamo J.E., Liu T., Schmeisser F., Ye Z. Optimizing viral protein yield of influenza virus strain A/Vietnam/1203/2004 by modification of the neuraminidase gene. J Virol 2009, 83(May (9)):4023-4029.